MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progress in its collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care.

People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...

LIMERICK Post satirical columnist Sean Mellor relays all the latest antics from the chambers of Limerick City and County Council.